Financhill
Back

SoftBank Group Corp. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
36

SFTBY
SoftBank Group Corp.

Last Price:
$51.01
Seasonality Move:
3.41%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.85
Seasonality Move:
11.58%
Sell
36
SoftBank Group Corp. (SFTBY) is a Sell

Is SoftBank Group Corp. a Buy, Sell or Hold?

  • The current SoftBank Group Corp. [SFTBY] share price is $53.57. The Score for SFTBY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SFTBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SFTBY Stock Price Chart

What is SoftBank Group Corp.'s stock price today?

  • The SoftBank Group Corp. share price today is $53.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SFTBY is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

SFTBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.2 Sell
Relative Strength Index (14 RSI): 39.65 Sell
Chaikin Money Flow: 249255 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

SFTBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.63 Sell
20-day SMA: 56.27 Sell
50-day SMA: 68.08 Sell
200-day SMA: 44.71 Buy
8-day EMA: 55.93 Sell
20-day EMA: 58.51 Sell
50-day EMA: 62.09 Sell
200-day EMA: 50.29 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

SoftBank Group Corp. Earnings Growth & SFTBY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

SoftBank Group Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):